Format

Send to

Choose Destination

See 1 citation found using an alternative search:

Am J Cardiol. 2006 Jun 19;97(12A):59G-65G. Epub 2006 Apr 7.

Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.

Author information

1
Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California 94305-5405, USA. hlatky@stanford.edu

Abstract

Diabetes mellitus and coronary artery disease (CAD) commonly coexist, and thus effective, cost-effective management strategies are needed. Intensive management of diabetes has been shown to increase medical costs while yielding better outcomes, with an acceptable cost-effectiveness ratio of <50,000 dollars per life-year added. On the basis of clinical trial findings in the 1970s and 1980s, coronary bypass surgery was cost-effective compared with medical therapy in the treatment of extensive CAD. Few trials have compared angioplasty with medical therapy, and its cost-effectiveness is not well established. The economic outcomes of contemporary coronary revascularization, especially angioplasty, compared with contemporary medical therapy must be evaluated. The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial will collect extensive economic data and examine the cost-effectiveness of alternative strategies to manage diabetes and CAD in patients with both disorders.

PMID:
16813739
DOI:
10.1016/j.amjcard.2006.03.014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center